CancerFree Biotech-preview

Cancerfree

CancerFree Biotech

Private

TaipeiHealthcare & Life Scienceshttps://cancerfree.io/

Last Round

Accelerator

Jul 1, 2023

Total Funding Raised

$1.11M

Company Overview

CancerFree Biotech is a biotechnology company that provides a circulating tumor cell-derived organoid platform designed to predict patient responses to cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

precision oncologyex vivo drug sensitivity testingcirculating tumor cell-derived organoidsCDOcirculating tumor cellsCTCliquid biopsytumor avatarpatient-derived organoidsorganoid culturepersonalized cancer treatmentdrug discovery servicescancer treatment selectionclinical trial supportCRO services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CancerFree Biotech Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CancerFree Biotech Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Jul 1, 2023
Seed	Nov 8, 2022
Accelerator	Sep 28, 2021
Grant	Aug 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Amber Wu

Chief Operating Officer, Co-Founder

Founding Team

Po Chen

Chief Executive Officer

Executive Team

Yihsuan Chen

Chief Product Officer

Executive Team

CancerFree Biotech Investors

Notable investors and investment history

Investor	Rounds
Taipei City Government	Grant
Sustainable Impact Capital	Seed
Berkeley SkyDeck Fund	Accelerator
Draper Associates	Seed
Taipei Medical University	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 1, 2026
Monthly visitors increased 67% MoM.
Nov 10, 2025
Monthly visitors grew 44% MoM, reaching 2.6K.

View all signals

CancerFree Biotech Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CancerFree Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CancerFree Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersTaipei

Employee Range20

Year Founded2018

Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.